NEPHROLOGY is a leading academic journal published by Wiley, dedicated to advancing research and discussions in the fields of Nephrology and Medicine. With an ISSN of 1320-5358, this journal has consistently demonstrated its significance and impact, reflecting a Q2 category ranking in both Medicine (miscellaneous) and Nephrology as of 2023. Covering a comprehensive range of topics since its inception in 1995, NEPHROLOGY provides a vital platform for researchers, practitioners, and students alike to explore the latest advancements, innovative treatments, and diverse challenges within the field. Although it does not operate under an open access model, the journal remains highly regarded, with a commendable Scopus rank of #27 out of 81 in Nephrology, positioning it in the 67th percentile among its peers. Located in the United Kingdom, NEPHROLOGY invites submissions that push the boundaries of knowledge, ultimately striving to enhance the understanding of renal health and disease.

NEFROLOGIA is a preeminent scientific journal published by the SOCIEDAD ESPAÑOLA DE NEFROLOGÍA DR. RAFAEL MATESANZ, specializing in cutting-edge research and clinical advancements in the field of nephrology. Established in 1981 and continuing through 2024, this journal serves as a crucial platform for nephrologists, researchers, and healthcare professionals to disseminate knowledge and foster dialogue on critical issues affecting kidney health. With its ISSN 0211-6995 and E-ISSN 1989-2284, NEFROLOGIA is indexed in prestigious databases, ranking #35 out of 81 in the Scopus Medicine Nephrology category, reflecting its significance within the medical community. Although it does not currently offer open access, the journal ensures wide accessibility and readership through institutional subscriptions. Researchers and clinicians are invited to contribute their findings and reviews, advancing our understanding and treatment of renal diseases. Through its commitment to high scholarly standards and impactful research, NEFROLOGIA remains a vital resource for those dedicated to improving kidney care and advancing nephrology sciences.

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

The American Journal of Kidney Diseases, published by W B Saunders Co-Elsevier Inc, stands as a premier academic resource in the field of nephrology, with an impressive impact factor that highlights its significance in advancing kidney health research. Since its inception in 1981, this journal has consistently provided a platform for innovative studies and critical reviews that shape clinical practices and policies in kidney disease management, achieving a prestigious Q1 ranking within the nephrology category as of 2023. With an H-index reflective of its research dynamism and influence, the journal has become an essential read for professionals, researchers, and students keen on the latest scientific advancements. While the journal does not offer Open Access, it continues to maintain high standards for the quality and relevance of its published content, making it indispensable for those dedicated to understanding and combating kidney diseases. Its address is located in Philadelphia, PA, further solidifying its commitment to fostering knowledge in the United States and beyond.

NEPHRON is a premier peer-reviewed academic journal dedicated to advancing the field of nephrology and renal medicine. Published by KARGER, renowned for its commitment to quality research, NEPHRON serves as a vital resource for researchers, clinicians, and students interested in the latest findings and developments in kidney health. With an ISSN of 1660-8151 and an E-ISSN of 2235-3186, the journal ensures wide accessibility and dissemination of knowledge in the renal domain. Although specific impact metrics such as the HIndex are presently unavailable, NEPHRON's emphasis on Open Access publishing greatly enhances its visibility and accessibility, allowing groundbreaking research to reach a global audience. Through a comprehensive scope that encompasses clinical studies, basic research, and translational science, NEPHRON contributes significantly to the understanding and treatment of kidney diseases. Join the vibrant community of professionals and scholars who are shaping the future of nephrology by engaging with the wealth of knowledge presented in NEPHRON.

THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.

SEMINARS IN NEPHROLOGY, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier journal in the field of nephrology, with a notable impact factor in its category. With its dedicated scope spanning significant developments from 1981 to 2024, this journal provides an essential platform for researchers, clinicians, and students to explore critical advances in renal medicine. Noteworthy for its classification in the Q1 quartile of nephrology journals, SEMINARS IN NEPHROLOGY ranks #18 out of 81 in Scopus, placing it in the 78th percentile of its field, which underscores its influence and contribution to contemporary research. While it currently does not offer open access, the journal remains a vital resource for anyone seeking to deepen their understanding of nephrological advancements and complexities. With an established address located at 1600 John F. Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, it continues to draw a global readership committed to the pursuit of knowledge in kidney health and disease.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.